NCT06305832: Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 102 planned
- Started
- 7 Sep 2023
- Primary completion
- Mar 2028
- Arms
- Rezvilutamide +ADT+ SRT
- Results
- None posted
- 7 Sep 2023: Trial started
- 12 Mar 2024: Trial registered